Partner Content Partner Content Disruptive Technologies in Pharma 2020 - the "Healthcare Dis... AI in Pharma
Partner Content Partner Content Interview with OnDigital Health Consulting ahead of Disrupti... SMi is delighted to present the launch of the Disruptive Technologies in Pharma conference taking place on the 20th – 21st January 2020, in London.
News Could a Novo error set up early GLP-1 generics in Canada? Reports say Novo Nordisk may have inadvertently let generics of its GLP-1 drug semaglutide for diabetes and obesity launch in Canada early next year.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
